Mengting Shu

Statistics

Publications

Citations

182

H-Index

Active since

2017

Affiliations

First Affiliated Hospital of Harbin Medical University(Current)

Harbin Medical University

Mengting Shu is an author at First Affiliated Hospital of Harbin Medical University specializing in autophagy in cancer, autophagy, and molecular oncology.

Publications per year

2017–2019

Publications

Nitazoxanide, an antiprotozoal drug, inhibits late-stage autophagy and promotes ING1-induced cell cycle arrest in glioblastoma

Xiaoxiong Wang, Chen Shen, Zhendong Liu et al. · Cell Death and Disease · 2018 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking

Boxian Zhao, Chen Shen, Zhixing Zheng et al. · Cellular Physiology and Biochemistry · 2018 · 46 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Raddeanin a Suppresses Glioblastoma Growth by Inducing ROS Generation and Subsequent JNK Activation to Promote Cell Apoptosis

Fei Peng, Xiaoxiong Wang, Mengting Shu et al. · Cellular Physiology and Biochemistry · 2018 · 30 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma

Mengting Shu, Junyi Ye, Xiaoxiong Wang et al. · BMC Cancer · 2019 · 24 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Isogambogenic Acid Inhibits the Growth of Glioma Through Activation of the AMPK-mTOR Pathway

Wenyang Zhao, Fei Peng, Mengting Shu et al. · Cellular Physiology and Biochemistry · 2017 · 20 citations · Full text

Life Sciences, Oncology, Pharmacology +17

1–5 of 5